Skip to main content

Advertisement

SpringerLink
Log in

Hyperhomocysteinemia in patients with Crohn’s disease

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Background

Thromboembolic complications have been reported in patients with Crohn’s disease. Among the contributing factors, hyperhomocysteinemia has been described, although controversial data exist. The aim of our study was to assess the incidence of hyperhomocysteinemia in a nonselected group of patients with Crohn’s disease and to determine whether it might represent a risk marker for thrombosis in such patients.

Methods

Fifty consecutive patients were recruited, and clinical and laboratory variables were compared between those without and those with hyperhomocysteinemia. In the latter, gene mutations in N5-N10-methyltetrahydrofolate reductase were searched for, and clinical and laboratory variables were related to hyperhomocysteinemia. The presence/absence of thrombotic episodes in both groups was determined.

Results

Both groups had similar clinically active disease, with higher C-reactive protein values found in those with hyperhomocysteinemia. Hyperhomocysteinemia was found in 46 % of patients. Of these, 74 % had moderate, 13 % intermediate, and 13 % severe increase in serum homocysteine levels. No relationship was found between homocysteine levels, and age, vitamin B12 levels, folic acid levels, Crohn’s Disease Activity Index score, and CRP values. Gene mutations were found in 5 (22 %) patients, 2 homozygotes and 3 heterozygotes. None of the patients with or without hyperhomocysteinemia had episodes of venous or arterial thrombosis, or stroke.

Conclusions

Hyperhomocysteinemia is frequent in patients with Crohn’s disease, and it could be a cofactor for the pathogenesis of thrombotic episodes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Vrij AA, Rijken J, van Wersch JW, Stockbrügger RW (2003) Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis. Pathophysiol Haemost Thromb 33:75–83

    Article  PubMed  CAS  Google Scholar 

  2. Grainge MJ, West J, Card TR (2010) Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study. Lancet 375:657–663

    Article  PubMed  Google Scholar 

  3. Kappelman MD, Horvath-Puho E, Sandler RS et al (2011) Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study. Gut 60:937–943

    Article  PubMed  Google Scholar 

  4. Miehsler W, Reinisch W, Valic E et al (2004) Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism? Gut 53:542–548

    Article  PubMed  CAS  Google Scholar 

  5. Cattaneo M, Vecchi M, Zighetti ML et al (1998) High prevalence of hyperhomocysteinemia in patients with inflammatory bowel disease: a pathogenic link with thromboembolic complications? Thromb Haemost 80:542–545

    PubMed  CAS  Google Scholar 

  6. Mahmood A, Needham J, Prosser J et al (2005) Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 17:739–744

    Article  PubMed  CAS  Google Scholar 

  7. Oldenburg B, Fijnheer R, van der Griend R, vanBerge-Henegouwen GP, Koningsberger JC (2000) Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications? Am J Gastroenterol 95:2825–2830

    Article  PubMed  CAS  Google Scholar 

  8. Ray JG (1998) Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Int Med 158:2101–2106

    Article  CAS  Google Scholar 

  9. Cattaneo M (1999) Hyperhomocysteinemia, atherosclerosis and thrombosis. Thromb Haemost 81:165–176

    PubMed  CAS  Google Scholar 

  10. Oussalah A, Guéant JL, Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34:1173–1184

    Article  PubMed  CAS  Google Scholar 

  11. Satsangi J, Silverberg MS, Vermeire S, Colombel JF (2006) The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 55:749–753

    Article  PubMed  CAS  Google Scholar 

  12. Stange EF, Travis SP, Vermeire S et al (2006) European evidence based consensus on the diagnosis and management of Crohn’s disease: definitions and diagnosis. Gut 55(Suppl 1):i1–i15

    Article  PubMed  Google Scholar 

  13. Walters TD, Steinhart AH, Bernstein CN et al (2011) Validating Crohn’s disease activity indices for use in assessing postoperative recurrence. Inflamm Bowel Dis 17:1547–1556

    Article  PubMed  CAS  Google Scholar 

  14. Accinni R, Campolo J, Bartesaghi S et al (1998) High-performance liquid chromatographic determination of total plasma homocysteine with or without internal standards. J Chromatogr A 828:397–400

    Article  PubMed  CAS  Google Scholar 

  15. Casella G, Bassotti G, Villanacci V et al (2011) Is hyperhomocysteinemia relevant in patients with celiac disease? World J Gastroenterol 17:2941–2944

    Article  PubMed  Google Scholar 

  16. Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354:407–413

    Article  PubMed  CAS  Google Scholar 

  17. Kluijtmans LA, van den Heuvel LP, Boers GH et al (1996) Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. Am J Hum Genet 58:35–41

    PubMed  CAS  Google Scholar 

  18. Kendall M (1938) A new measure of rank correlation. Biometrika 30:81–89

    Google Scholar 

  19. Irving PM, Pasi KJ, Rampton DS (2005) Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 3:617–628

    Article  PubMed  CAS  Google Scholar 

  20. Papa A, Scaldaferri F, Danese S et al (2008) Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects. Dig Dis 26:149–155

    Article  PubMed  Google Scholar 

  21. Andersohn F, Waring M, Garbe E (2010) Risk of ischemic stroke in patients with Crohn’s disease: a population-based nested case-control study. Inflamm Bowel Dis 16:1387–1392

    Article  PubMed  Google Scholar 

  22. Spina L, Saibeni S, Battaglioli T, Peyvandi F, de Franchis R, Vecchi M (2005) Thrombosis in inflammatory bowel diseases: role of inherited thrombophilia. Am J Gastroenterol 100:2036–2041

    Article  PubMed  CAS  Google Scholar 

  23. Spek CA, ten Kate FJ, te Velde AA (2007) Factor V Leiden and the etiology of inflammatory bowel disease. Thromb Haemost 98:670–673

    PubMed  CAS  Google Scholar 

  24. Koutroubakis IE, Dilaveraki E, Vlachonikolis IG et al (2000) Hyperhomocysteinemia in Greek patients with inflammatory bowel disease. Dig Dis Sci 45:2347–2351

    Article  PubMed  CAS  Google Scholar 

  25. Bjerregaard LT, Nederby NJ, Fredholm L, Brandslund I, Munkholm P, Hey H (2002) Hyperhomocysteinaemia, coagulation pathway activation and thrombophilia in patients with inflammatory bowel disease. Scand J Gastroenterol 37:62–67

    Article  PubMed  Google Scholar 

  26. Saibeni S, Lecchi A, Meucci G et al (2005) Prevalence of hyperhomocysteinemia in adult gluten-sensitive enteropathy at diagnosis: role of B12, folate, and genetics. Clin Gastroenterol Hepatol 3:574–580

    Article  PubMed  CAS  Google Scholar 

  27. Peyrin-Biroulet L, Guéant-Rodriguez RM, Chen M, Bronowicki JP, Bigard MA, Guéant JL (2008) Association of MTRR 66A>G polymorphism with superoxide dismutase and disease activity in patients with Crohn’s disease. Am J Gastroenterol 103:399–406

    Article  PubMed  CAS  Google Scholar 

  28. Kallel L, Feki M, Sekri W et al (2011) Prevalence and risk factors of hyperhomocysteinemia in Tunisian patients with Crohn’s disease. J Crohns Colitis 5:110–114

    Article  PubMed  Google Scholar 

  29. Lambert D, Benhayoun S, Adjalla C et al (1996) Crohn’s disease and vitamin B12 metabolism. Dig Dis Sci 41:1417–1422

    Article  PubMed  CAS  Google Scholar 

  30. Roblin X, Germain E, Phelip JM et al (2006) Factors associated with hyperhomocysteinemia in inflammatory bowel disease: prospective study in 81 patients. Rev Med Interne 27:106–111

    Article  PubMed  CAS  Google Scholar 

  31. Saibeni S, Cattaneo M, Vecchi M et al (2003) Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98:112–117

    Article  PubMed  CAS  Google Scholar 

  32. Younes-Mhenni S, Derex L, Berruyer M et al (2004) Large-artery stroke in a young patient with Crohn’s disease. Role of vitamin B6 deficiency-induced hyperhomocysteinemia. J Neurol Sci 221:113–115

    Article  PubMed  CAS  Google Scholar 

  33. Lipinski S, Bremer L, Lammers T, Thieme F, Schreiber S, Rosenstiel P (2011) Coagulation and inflammation Molecular insights and diagnostic implications. Hamostaseologie 31:94–102

    Article  PubMed  CAS  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Medical Department, Desio Hospital, Desio, Monza and Brianza, Italy

    G. Casella & V. Baldini

  2. Clinical Pathology Department, Desio Hospital, Desio, Monza and Brianza, Italy

    C. Di Bella

  3. Digestive Endoscopy Unit, Desio Hospital, Desio, Monza and Brianza, Italy

    E. Di Marco

  4. Laboratory Medicine Unit, Desio Hospital, Desio, Monza and Brianza, Italy

    M. Piatti

  5. Pathology Section, Department of Laboratory Diagnostics, Spedali Civili, Brescia, Italy

    V. Villanacci

  6. Gastroenterology and Hepatology Section, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy

    E. Antonelli, S. Bologna & G. Bassotti

  7. Clinica di Gastroenterologia ed Epatologia, Ospedale Santa Maria della Misericordia, Piazzale Menghini,1, 06156, San Sisto, Perugia, Italy

    G. Bassotti

Authors
  1. G. Casella
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Antonelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Di Bella
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Di Marco
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Piatti
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. V. Villanacci
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. S. Bologna
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. V. Baldini
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Bassotti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Bassotti.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Casella, G., Antonelli, E., Di Bella, C. et al. Hyperhomocysteinemia in patients with Crohn’s disease. Tech Coloproctol 17, 497–500 (2013). https://doi.org/10.1007/s10151-013-0992-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-013-0992-0

Keywords

Search

Navigation